Connect with us

Technology

Piramal Pharma Limited Announces Results for Q4 and Full-year FY26

Published

on

MUMBAI, India, April 28, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full-year ended 31st March 2026.

Consolidated Financial Highlights

(in ₹ Crores or as stated)

Particulars

Q4FY26

Q4FY25

YoY %

FY26

FY25

YoY %

Revenue from Operations

2,752

2,754

(0) %

8,869

9,151

(3) %

   CDMO

1,708

1,788

(4) %

4,915

5,447

(10) %

   CHG

755

705

7 %

2,703

2,633

3 %

   PCH

320

274

17 %

1,274

1,093

17 %

EBITDA

507

603

(16) %

1,135

1,580

(28) %

EBITDA Margin

18 %

22 %

13 %

17 %

PAT Before Expectational Item

167

154

9 %

(130)

91

NM

Exceptional Item1

(176)

NM

(196)

NM

PAT After Expectational Item

(9)

154

NM

(326)

91

NM

1. During the quarter, the management has recognized an impairment loss of ₹. 176Cr in relation to intangible assets under development. Based on a reassessment incorporating changes in market conditions and updated commercial viability estimates, management concluded that the probable future economic benefits from the asset are no longer expected to be adequate to justify further capital deployment.  Accordingly, the carrying amount has been written down in full.

Key Highlights

Revenue – Growth was impacted by inventory destocking, slower early-stage order inflows in H1FY26, and softer traction in inhalation anesthesia across ex‑US markets. Adjusted for inventory destocking, we delivered YoY growth in Q4 and FY26.EBITDA Margin – Despite lower revenues, impact on EBITDA was partly offset by our efforts towards cost optimization and operational excellence.Capex – US$94Mn invested in FY26 across growth and maintenance projects. Lexington and Riverview expansions on track. Seeing good customer interest.Net Debt – No increase over FY25.

Nandini Piramal, Chairperson, Piramal Pharma Limited said, “FY26 was a transitional year, shaped by external disruptions and certain business-specific factors. Despite these challenges, we exited the year on a stronger note, with clear momentum across all our businesses. The meaningful recovery in biopharma funding seen from Sep’25,  is translating into good RFP momentum and healthy pick up in order inflows in our  CDMO business. In the CHG business, the recently completed Kenalog® acquisition alongside ramp up of inhalation anesthesia sales in ex-US markets are expected to be key growth drivers. Our Consumer Healthcare business is also well positioned to sustain its growth momentum with margin improvement driven by Power Brands and rapid growth in e‑commerce.

Overall, all three businesses are well positioned to deliver growth in FY27, accompanied by accelerated growth in EBITDA and PAT.”

Key Business Highlights

Contract Development and Manufacturing Organization (CDMO):

Healthy traction in RFPs and order inflows in H2FY26 driven by stronger US biopharma funding (up YoY 75% in H2FY26, 30% in FY26) and M&A activity. (Industry Source)Overseas sites seeing rising demand from shifting customer geographical preferences and strong growth in differentiated areas such as ADC, HP API, on‑shore injectables and drug product capabilities.US$90Mn Capex on track to scale sterile injectable and payload-linker capacities at Lexington and Riverview sites.Net Promoter Score of 60 – surpassing industry average. Meaningful improvement in execution with stronger performance across key operational matrices, driven by our operational excellence initiatives.209 customer site audits in FY26 vs. 165 in FY25 — highest ever. Reflecting heightened customer engagement, deeper technical interactions, and the growing complexity of programs we support.Maintained our Best-in-Class Quality Track Record – Successfully closed 38 regulatory inspections, including 3 USFDA inspections in FY26. Continue to maintain our ‘Zero OAI’ status.

Complex Hospital Generics (CHG):

Completed Kenalog® acquisition

– Upfront consideration of US$35Mn, and contingent consideration of up to US$65Mn.
– Broadens CHG portfolio, adds revenues with minimal incremental cost, and expands presence in US, Europe & Asia Pacific.
– Niche brand with complex manufacturing process. EBITDA margins in line with CHG business.

Inhalation Anesthesia (IA) 

– Continue to maintain leadership with 47% market share – up from 45% in Mar’24. (Source:- IQVIA)
– Initiated Sevoflurane supplies from lower cost Digwal facility in select RoW markets. Expect traction to build going ahead.

Intrathecal Therapy – Maintained our #1 Rank in intrathecal Baclofen segment in the US. (Source:- IQVIA)Injectable Pain Management – Continue to work with our supplier to resolve supply constraints.

Piramal Consumer Healthcare (PCH):

Power Brands continued growth momentum with 24% YoY growth in FY26, contributing 52% to PCH sales. Little’s, Lacto Calamine, CIR, and i-range remained primary driver of growth.New Product Launches – Fewer, high‑potential product launches with better success rates. Launched 31 new products and SKU in FY26. Focus on premiumization of portfolio.E-commerce sales grew at 48% rate YoY in FY26, contributing about 27% to PCH sales. Evolve product mix toward premium offerings and high margin channel (e.g. quick commerce).Invested about 12% of PCH sales on Media and Trade Promotion in FY26. Optimizing the media mix – Social Media, Television, Influencers, etc.

Consolidated Profit and Loss Statement

(in ₹ Crores or as stated)

Particulars

Quarterly

Full-year

Q4FY26

Q4FY25

YoY  %

Q3FY26

QoQ  %

FY26

FY25

YoY  %

Revenue from Operations

2,752

2,754

(0) %

2,140

29 %

8,869

9,151

(3) %

Other Income

46

42

10 %

43

7 %

213

135

58 %

Total Income

2,798

2,796

0 %

2,183

28 %

9,082

9,286

(2) %

Material Cost

1,056

955

11 %

786

34 %

3,239

3,232

0 %

Employee Expenses

586

612

(4) %

600

(2) %

2,416

2,307

5 %

Other Expenses

650

626

4 %

558

16 %

2,293

2,167

6 %

EBITDA

507

603

(16) %

239

112 %

1,135

1,580

(28) %

Interest Expenses

83

104

(20) %

89

(7) %

341

422

(19) %

Depreciation

218

243

(10) %

213

3 %

831

816

2 %

Share of Net Profit of Associates

14

16

(16) %

10

32 %

57

73

(22) %

Profit Before Tax

219

273

(20) %

(53)

NM

20

415

(95) %

Tax

52

119

(57) %

42

22 %

150

324

(54) %

Net Profit after Tax

167

154

9 %

(95)

NM

(130)

91

NM

Exceptional item1

(176)

NM

(41)

NM

(196)

NM

Net Profit after Tax after Exceptional Item

(9)

154

NM

(136)

NM

(326)

91

NM

During the quarter, the management has recognized an impairment loss of Rs. 176Cr in relation to intangible assets under development. Based on a reassessment incorporating changes in market conditions and updated commercial viability estimates, management concluded that the probable future economic benefits from the asset are no longer expected to be adequate to justify further capital deployment.  Accordingly, the carrying amount has been written down in full.

Consolidated Balance Sheet

(in ₹ Cr.)

   Key Balance Sheet Items

As at

31-Mar-26

31-Mar-25

Total Equity

8,162

8,125

Net Debt

4,140

4,199

Total

12,302

12,324

Net Fixed Assets

9,784

9,110

    Tangible Assets

4,843

4,534

    Intangible Assets including goodwill

3,841

3,599

    CWIP (including IAUD2)

1,100

977

Net Working Capital

2,057

2,798

Other Assets3

462

416

Total Assets

12,302

12,324

2. IAUD – Intangible Assets Under Development; 3. Other Assets include Investments and Deferred Tax Assets (Net)

Earnings Conference Call

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 29th April 2026 from 9:30 AM to 10:15 AM (IST) to discuss its Q4 and full-year FY26 Results.

The dial-in details for the call are as under:

Event

Location & Time

Telephone Number

Conference call on 29th April 2026

India – 09:30 AM IST

+91 22 6280 1461 / +91 22 7115 8320 (Primary Number)

1 800 120 1221 (Toll free number)

USA – 12:00 AM

(Eastern Time – New York)

Toll free number

18667462133

UK – 05:00 AM

(London Time)

Toll free number

08081011573

Singapore – 12:00 PM

(Singapore Time)

Toll free number

8001012045

Hong Kong – 12:00 PM

(Hong Kong Time)

Toll free number

800964448

Express Join with Diamond Pass™

Please use this link for prior registration to reduce wait time at the time of joining the call –Click here

About Piramal Pharma Limited:

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 171 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and Piramal Consumer Healthcare (PCH) business, selling over-the-counter consumer and wellness products. In addition, one of PPL’s associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics / bio-therapeutics and vaccine segments.

For more information, visit:  Piramal Pharma | LinkedIn

1. Includes one facility via PPL’s minority investment in Yapan Bio.

Logo – https://mma.prnewswire.com/media/1855206/5942698/Piramal_Pharma_Limited_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-limited-announces-results-for-q4-and-full-year-fy26-302756234.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Global Times: How fresh dynamics, fierce competition reshape China’s auto market

Published

on

By

BEIJING, Aug. 30, 2026 /PRNewswire/ — China’s auto market today is more dynamic – and more fiercely competitive – than ever before.

The pace of new-model launches has broken industry records. In the first half of this year, more than 100 all-new models built on new platforms or featuring major generational upgrades entered the market, alongside hundreds of modified and upgraded models. Gasoline-powered vehicles made up less than 20 percent of the all-new models.

This is an unprecedented intensity of supply and an unprecedented speed of product iteration in the history of global automotive development.

Historically, at the peak of Germany’s auto industry, the number of newly developed production models launched in a full year was around 100. China introduced more all-new models in just six months than major European and US markets typically do in a full year. Compared with China’s own gasoline-car sales peak in 2016-17, the annual number of all-new models launched at the time was less than one-third of the comparable total in the first half of this year.

Such breakneck iteration is possible only in the intelligent era. As China enters the opening year of the 15th Five-Year Plan period (2026-30), its auto market is undergoing profound changes.

Profound changes

On the demand side, NEVs have become the mainstream choice for new-car buyers, fundamentally reversing the previous balance between gasoline-powered and electric vehicles.

After monthly NEV retail penetration surpassed 50 percent at the end of 2025, the retail penetration rate of new-energy passenger vehicles remained above 60 percent from April through July 2026, reaching 65.1 percent in July.

For consumers, NEVs are increasingly the preferred choice. Even steep price cuts on gasoline-powered vehicles have failed to reverse this shift in purchasing behavior. Research shows that more than 80 percent of gasoline-car owners choose an NEV when replacing their vehicles. Meanwhile, intelligent in-car technologies are moving from premium options to standard features, with competition increasingly shifting toward an era of “AI-defined vehicles.”

On the supply side, China has built a largely self-sufficient domestic industrial chain, reshaping the traditional global division of labor in the auto industry.

China has achieved a high degree of self-reliance in batteries, electric motors and electronic controls, as well as silicon carbide power modules and electric-drive systems, reducing its dependence on powertrain technologies long dominated by overseas suppliers. Chinese companies now occupy seven of the world’s top 10 places in installed power-battery capacity, with a combined market share of more than 72 percent. China’s national battery safety standards are also beginning to be introduced overseas.

More telling is the rise of “reverse joint ventures,” with joint-venture brands increasingly turning to Chinese technologies. On March 13, the ID. UNYX 08 – the first model jointly developed by Volkswagen and XPeng – rolled off the production line at Volkswagen Anhui’s plant. Audi, meanwhile, has teamed up with SAIC Motor to create the China-focused AUDI brand, which makes extensive use of Chinese-developed platforms and intelligent technologies.

The rules formed in the gasoline-car era are losing relevance, while new dynamics are rapidly taking shape in the NEV era. The much-discussed problem of excessive competition, or “involution,” therefore needs to be examined through a new market logic.

First, just how “new” are all these new models?

Of the hundreds of models launched in the first half, most were facelifts, configuration tweaks or niche variants, leaving some models facing refreshed rivals almost as soon as they hit the market.

This reflects a fundamental change in supply capacity made possible by technology in the intelligent era.

Gasoline-powered vehicles are constrained by complex mechanical architectures, making major hardware changes costly. Developing a new model typically takes 36 to 48 months, while a basic model may remain in use for five to 10 years. NEVs, by contrast, use modular electric platforms, software and over-the-air (OTA) updates, allowing derivative models to be developed in just six to 12 months – closer to the pace of consumer electronics. The logic of auto production has fundamentally changed.

Growth curve

The next question is: What has happened to the market’s growth curve?

From January to July 2026, China produced 9.014 million NEVs and sold 9.007 million, up 9.5 percent and 9.6 percent year-on-year, respectively. But the market has become increasingly differentiated, with a large number of Chinese brands posting double-digit growth. The 10 fastest-growing brands were concentrated in the mid- to high-end pure-electric segment, with Chinese brands overwhelmingly dominating the list. Tesla China was the only foreign brand among the top 10.

More notably, sales of NEVs priced above 400,000 yuan rose 46 percent year-on-year in the first half, with Chinese brands taking nearly 60 percent of the segment. Their growth has been driven not by low prices, but by technology, intelligent features and stronger brands. Those losing ground, by contrast, are mainly joint-venture brands slow to transform, low-end micro-EVs and highly similar models.

This changing growth curve points to an important trend: upgrading and vehicle replacement are becoming the dominant forces driving demand.

China now has 371 million vehicles on the road, the world’s largest fleet and nearly one-quarter of the global total. Gasoline-powered vehicles account for 86.81 percent of the fleet and are 8.2 years old on average, while many first-generation NEVs are nearing the end of their warranty periods. This is setting the stage for the world’s largest vehicle-replacement cycle, with the 15th Five-Year Plan period becoming a key window for replacement demand and mid- to high-end consumption.

Half-year earnings announcements released in July showed a sharp contrast between weaker profits at some automakers and strong earnings at leading supply-chain companies. This shift in profits should be viewed in the broader context of industrial evolution.

For decades, key auto components and advanced technologies were dominated by overseas companies, with nearly all of the substantial profits they generated flowing abroad. Today, Chinese supply-chain companies increasingly master key technologies through in-house R&D, allowing healthy profits to support long-term investment in frontier technologies.

New trends

Taken together, the new trends emerging in models, sales and profitability in China’s NEV industry in the first half of 2026 offer important insights into where the market is heading.

One conclusion is becoming increasingly clear: China’s auto market is both the world’s largest arena for vehicle replacement and a bellwether for the next round of NEV upgrading and iteration, helping determine the cycle and pace of transformation across the global auto industry.

Unprecedented market potential, rapid innovation and fierce competition are converging in the same market, creating a uniquely powerful draw for global automakers. In an open market, some companies gaining ground while others lose – it is a natural outcome of competition, not a zero-sum game.

“You only get stronger by getting into the thick of competition,” BYD Executive Vice President He Zhiqi wrote recently on social media, capturing a sentiment shared by many Chinese entrepreneurs.

Geely Holding Group founder Li Shufu has said that the auto industry should not fight price wars, but instead compete on technology, services, quality and brands.

Price wars are unsustainable, and destructive “involution” should be avoided. Vigorous competition, however, is what defines a major market.

A growing consensus is taking shape among both Chinese and foreign automakers: competition must shift from price to value and move onto a new track of high-quality development, with companies engaging in healthy competition through diverse technological pathways, stronger core capabilities and continuous improvements in user experience.

For Chinese consumers – particularly younger buyers who grew up with smartphones, this kind of vibrant, innovative market with an abundance of choice is precisely what they want.

View original content:https://www.prnewswire.com/news-releases/global-times-how-fresh-dynamics-fierce-competition-reshape-chinas-auto-market-302864390.html

SOURCE Global Times

Continue Reading

Technology

ATTACK SHARK Unveils R86 HE Carbon Fiber Magnetic Switch Gaming Keyboard, Redefining the 75% Competitive Keyboard Experience

Published

on

By

NEW YORK, Aug. 30, 2026 /PRNewswire/ — Gaming peripheral brand ATTACK SHARK has announced the launch of the R86 HE Carbon Fiber Magnetic Switch Gaming Keyboard, a flagship model designed to elevate expectations for high-end competitive gaming keyboards. Scheduled for release on 7 September 2026, the R86 HE is among the few magnetic switch keyboards to combine a 75% layout with a carbon fiber composite top case, bringing together advanced materials, precision magnetic switch technology, refined acoustics, and extensive customization.

As magnetic switch technology becomes a key driver of innovation in the gaming peripheral market, user expectations have expanded beyond speed alone. Today’s players are increasingly seeking a combination of performance, build quality, sound, and personalization. The R86 HE answers those demands with a carbon fiber composite structure, tournament-grade magnetic switch performance, and a Hi-Fi-inspired acoustic design, creating a new-generation 82-key gaming keyboard that balances competitive capability with everyday usability.

Carbon Fiber Construction Meets Practical 75% Layout

The R86 HE features a compact 82-key, 75% layout that retains dedicated arrow keys and essential functions while saving valuable desk space. Designed for both competitive gaming and everyday productivity, it delivers functionality without the bulk of larger keyboards.

Its premium design combines a carbon fiber composite top case with anodized CNC aluminum alloy side accents, creating a distinctive flagship look inspired by high-performance materials. The forged carbon texture offers exceptional rigidity and durability, while carbon fiber composite keycaps provide a crisp, consistent typing feel suited to fast-paced gaming.

0.005mm Rapid Trigger Accuracy for Competitive Play

In competitive FPS titles, a perfectly timed counter-strafe can be the difference between landing a decisive shot and missing a critical opportunity. The R86 HE’s 0.005mm Rapid Trigger Accuracy enables extremely precise key reset and actuation control, helping players transition seamlessly between movement and aiming. Combined with a custom esports chipset featuring 256K scanning and an 8000Hz polling rate, the keyboard achieves response times as low as 0.08ms, delivering the speed and consistency needed for fast-paced competitive gameplay.

Hi-Fi Acoustics for a Refined Typing Experience

Magnetic switch keyboards are often defined by speed, but the R86 HE goes beyond raw performance. A five-layer sound-dampening structure, comprising PE foam, IXPE switch pads, PET acoustic film, switch socket foam, and bottom silicone padding, helps reduce unwanted resonance for a cleaner, more refined typing sound. A premium fiberglass positioning plate enhances stability and feedback, while custom Huano Glass Jade magnetic switches balance ultra-fast responsiveness with a crisp, satisfying acoustic profile.

Built for Personalization

The R86 HE supports multiple high-performance magnetic switches and independent curve tuning, enabling personalized actuation settings for different gaming styles.

Full-key RGB lighting and dual-side dynamic light strips add visual impact, while web-based and PC software provide convenient access to key mapping, switch adjustments, and other customization options.

More than a high-performance gaming keyboard, the ATTACK SHARK R86 HE represents a fusion of advanced materials, acoustic engineering, and competitive-grade technology. By combining a unique 75% layout, carbon fiber flagship design, Hi-Fi acoustics, and 0.005mm Rapid Trigger Accuracy, it introduces a distinctive new option for users seeking both elite performance and premium craftsmanship.

For more information, visit https://attackshark.com/ or connect with the brand on social media and Discord.

To place an order, visit ATTACK SHARK Amazon Store for the US, UK, Europe, Australia, Mexico, Saudi Arabia and Japan.

View original content to download multimedia:https://www.prnewswire.com/news-releases/attack-shark-unveils-r86-he-carbon-fiber-magnetic-switch-gaming-keyboard-redefining-the-75-competitive-keyboard-experience-302864384.html

SOURCE ATTACK SHARK

Continue Reading

Technology

Yaber Launches Cordless Vacuum HP20: TÜV-Tested 180AW Suction, SGS-certified H13 HEPA Filtration, and SenseCleanAI AI Detection Under $200

Published

on

By

NEW YORK, Aug. 30, 2026 /PRNewswire/ — Yaber announced the launch of the Yaber HP20 Cordless Vacuum Cleaner, redefining what budget–conscious consumers can expect, featuring TÜV–certified true 180AW suction, SGS–verified H13 HEPA filtration, and SenseClean AI that automatically adjusts power based on real-time debris detection.

TÜV–tested 180AW Suction Powerful Performance from Floor to Carpet

Compared to other low-aw vacuums, The HP20 delivers genuine TÜV–tested 180AW suction – a rarity in this price bracket. Its stiff–bristle roller brush effectively loosens embedded dirt from carpets and floors, while the powerful airflow lifts even stubborn debris, leaving surfaces spotless. Unlike ordinary vacuums, the HP20’s cyclone technology ensures consistent, fade–free performance from start to finish – so you never have to worry about weakening pickup halfway through cleaning.

SGS-certified H13 HEPA Filtration for Healthier Homes

Beyond visible dirt, the HP20 features a sealed 5–stage filtration system with H13 HEPA media, certified by SGS to capture 99.97% of microscopic particles, including fine dust, pollen, and pet dander under lab conditions. An anti–backflow design prevents contaminants from escaping back into the air – making it a top choice for families with children, pets, or allergy–sensitive members.

Auto-Suction Based on Dust Level by SenseClean AI Technology

No more manual mode switching. Equipped with Yaber’s SenseClean AI technology, the HP20 scans the floor thousands of times per second to detect dust levels in real time. It then automatically adjusts suction power – high for heavy messes, low for light dust – optimizing cleaning efficiency while maximizing battery life, so you clean smarter, not harder.

Visible Cleaning with Green LED Light and Versatile Attachments

To help users clean areas often overlooked, the HP20 incorporates a green LED dust detection light, revealing hidden dust, pet hair, and fine particles that ordinary lighting may miss.

Combined with an adjustable extension tube and multiple cleaning accessories, the HP20 easily converts into a handheld cleaner for stairs, furniture, sofas, car interiors, corners, baseboards, and other hard-to-reach spaces.

Pricing and Availability

The Yaber HP20 is now live on Amazon’s official Yaber store:https://www.amazon.com/gp/product/B0H2LWWYCX?maas=maas_adg_2F3844CE879126CA012EB35527CF1C50_afap_abs&ref_=aa_maas&tag=maas&th=1. For a limited time, apply code HP20PANPR at checkout to enjoy the exclusive launch price of $139.99. Don’t miss this opportunity to experience premium cleaning performance at an exceptional value.

View original content to download multimedia:https://www.prnewswire.com/news-releases/yaber-launches-cordless-vacuum-hp20-tuv-tested-180aw-suction-sgs-certified-h13-hepa-filtration-and-sensecleanai-ai-detection-under-200-302864366.html

SOURCE Yaber

Continue Reading

Trending